Business
FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers
FlyteHealth, a national leader in integrated cardio-kidney-metabolic care, today announced it will provide self-insured organizations with a new access pathway for obesity management medication from Eli Lilly and Company (Lilly) — supported by FlyteHealth's clinically rigorous, outcomes-driven care platform.
About this update from Eli Lilly And Company
[{"type":"text","content":"NEW CANAAN, Conn., Dec. 22, 2025 /PRNewswire/ -- FlyteHealth, a national leader in integrated cardio-kidney-metabolic care, today announced it will provide self-insured organizations with a new access pathway for obesity management medication from Eli Lilly and Company (Lilly) — supported by FlyteHealth's clinically rigorous, outcomes-driven care platform.","length":367,"tagName":"p"},{"type":"image","alt":"FlyteHealth (PRNewsfoto/FlyteHealth)","displaySize":"","headline":null,"caption":"FlyteHealth (PRNewsfoto/FlyteHealth)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":337,"url":"https://media.zenfs.com/en/prnewswire.com/0c1286c01ecf366f85838ebc95becd1a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Tzs5ExdtZqBX7dLiM.b3oQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTU5NDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/0c1286c01ecf366f85838ebc95becd1a","width":400,"height":337}},"href":"https://mma.prnewswire.com/media/2651314/FlyteHealth_Gray_Stacked_2x_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This is a milestone for the employer market: employers will be able to pair access to select Lilly medicines with a fully integrated, independently validated care model proven to improve cardio-kidney-metabolic outcomes, adherence, and long-term cost efficiency.","length":262,"tagName":"p"},{"type":"text","content":"A Model Purpose-Built to Address Employers' Most Pressing Challenges","length":72,"tagName":"p"},{"type":"text","content":"Obesity affects more than 100 million Americans and demand for cardio-kidney-metabolic treatment has surged, yet employers continue to face unclear costs and fragmented solutions, and significant concerns about long-term cost sustainability. This new self-insured employer model — offering FlyteHealth's comprehensive clinical care with access to Lilly's obesity management medicine — is designed to address these challenges head-on.","length":441,"tagName":"p"},{"type":"text","content":"FlyteHealth is launching this new direct to employer, manufacturer offering in addition to its existing program solutions. The goal for this new employer offering remains the same: Deliver world-class, evidence-based care, now to eligible members with an employer-focused offering. This will include FlyteHealth's:","length":3...